A temporary spike: Investigating Lennox-Gastaut syndrome incidence in the US following FDA approval of cannabidiol.
Saved in:
| Title: | A temporary spike: Investigating Lennox-Gastaut syndrome incidence in the US following FDA approval of cannabidiol. |
|---|---|
| Authors: | Marcinski Nascimento KJ; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Li Y; Department of Psychiatry, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA., Lin BY; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA., Dixon-Salazar T; Lennox-Gastaut Syndrome Foundation, San Diego, California, USA., Perry MS; Jane and John Justin Institute for Mind Health, Cook Children's Medical Center, Fort Worth, Texas, USA., Xu KY; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA., Nascimento FA; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. |
| Source: | Epileptic disorders : international epilepsy journal with videotape [Epileptic Disord] 2026 Apr; Vol. 28 (2), pp. 420-426. Date of Electronic Publication: 2026 Jan 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 100891853 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6945 (Electronic) Linking ISSN: 12949361 NLM ISO Abbreviation: Epileptic Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1950-6945 |
|---|---|
| DOI: | 10.1002/epd2.70168 |
